Patent · US Active

Method for differentiating between factor XIII deficiency states and fibrinogen deficiency states by means of thrombelastographic techniques

US7939288B2 · kind B2 · utility

6Cited by

1References

34Claims

0Family size

Assignee

CSL Behring AG · DE

Inventors

Erhardt Wrabetz · Hochheim, DE
Hubert Metzner · Marburg, DE
Wolfgang Korte

Key dates

Filing date	Feb 6, 2006
Grant date	May 10, 2011
Priority date	—
Expiry date	Mar 16, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q1/56
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The invention relates to a method for determining a factor XIII deficiency, a method for determining a fibrinogen deficiency, and a method for differentiating between a factor XIII deficiency and a fibrinogen deficiency by means of thrombelastographic techniques. On the basis of the evaluation of the thrombelastographic parameters, a rapid and a selective substitution of factor XIII and/or of fibrinogen in deficiency states is possible.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.